Khaitan & Co advised Lupin Limited in its acquisition of Huminsulin® brand from Eli Lilly and Company to range of products, including Huminsulin R, Huminsulin NPH, Huminsulin 50/50, and Huminsulin 30/70, through supply arrangements with Eli Lilly, India.
The core team consisted of Surbhi Kejriwal (Partner), Shailendra Bhandare (Partner), Vedika Bhandari (Principal Associate) and Dipshikha Dhar (Senior Associate) with assistance from the following:
Tax aspects: Vinita Krishnan (Executive Director) and Husain Bohra
(Senior Associate);
Intellectual Property aspects: Shouraseni Chakraborty
(Associate).
The Firm role was advising on drafting and negotiating the entire deal which included negotiating and drafting of the asset purchase, supply agreement, IP assignment agreement and other ancillary agreements.
Media Links / Press Releases